

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.82922819 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.82922819 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.49617656 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.49617656 |
| 5 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.27283771 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.18253645 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.71121495 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.71121495 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.71121495 |
| 10 | regulation of plasminogen activation (GO:0010755) | 5.58934852 |
| 11 | tryptophan metabolic process (GO:0006568) | 5.55878234 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.49221112 |
| 13 | protein-lipid complex assembly (GO:0065005) | 5.48282604 |
| 14 | intestinal cholesterol absorption (GO:0030299) | 5.46013353 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.40265375 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.29964197 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.13917683 |
| 18 | plasma lipoprotein particle organization (GO:0071827) | 5.04468797 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 4.97354780 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 4.79115350 |
| 21 | urea cycle (GO:0000050) | 4.74296610 |
| 22 | urea metabolic process (GO:0019627) | 4.74296610 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 4.74233265 |
| 24 | protein-lipid complex subunit organization (GO:0071825) | 4.73921455 |
| 25 | regulation of fibrinolysis (GO:0051917) | 4.72118673 |
| 26 | regulation of protein activation cascade (GO:2000257) | 4.69866664 |
| 27 | protein carboxylation (GO:0018214) | 4.59974687 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.59974687 |
| 29 | aromatic amino acid family metabolic process (GO:0009072) | 4.56276613 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 4.53026485 |
| 31 | alpha-linolenic acid metabolic process (GO:0036109) | 4.52305244 |
| 32 | cysteine metabolic process (GO:0006534) | 4.50242855 |
| 33 | bile acid metabolic process (GO:0008206) | 4.49760254 |
| 34 | complement activation, alternative pathway (GO:0006957) | 4.48611521 |
| 35 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.47339741 |
| 36 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.47339741 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.47163533 |
| 38 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.40194860 |
| 39 | alpha-amino acid catabolic process (GO:1901606) | 4.38995725 |
| 40 | regulation of apoptotic cell clearance (GO:2000425) | 4.37891173 |
| 41 | glutamate metabolic process (GO:0006536) | 4.36427405 |
| 42 | proline metabolic process (GO:0006560) | 4.34572768 |
| 43 | lysine catabolic process (GO:0006554) | 4.34120581 |
| 44 | lysine metabolic process (GO:0006553) | 4.34120581 |
| 45 | cellular ketone body metabolic process (GO:0046950) | 4.33964885 |
| 46 | coenzyme catabolic process (GO:0009109) | 4.33912627 |
| 47 | regulation of complement activation (GO:0030449) | 4.33701148 |
| 48 | reverse cholesterol transport (GO:0043691) | 4.32638074 |
| 49 | nitrogen cycle metabolic process (GO:0071941) | 4.31834600 |
| 50 | tyrosine metabolic process (GO:0006570) | 4.27255141 |
| 51 | acute-phase response (GO:0006953) | 4.26583259 |
| 52 | regulation of cholesterol esterification (GO:0010872) | 4.26281659 |
| 53 | epoxygenase P450 pathway (GO:0019373) | 4.21979595 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 4.19205895 |
| 55 | homocysteine metabolic process (GO:0050667) | 4.15813377 |
| 56 | acylglycerol homeostasis (GO:0055090) | 4.14527169 |
| 57 | triglyceride homeostasis (GO:0070328) | 4.14527169 |
| 58 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.11350382 |
| 59 | protein-lipid complex remodeling (GO:0034368) | 4.10751444 |
| 60 | macromolecular complex remodeling (GO:0034367) | 4.10751444 |
| 61 | plasma lipoprotein particle remodeling (GO:0034369) | 4.10751444 |
| 62 | regulation of triglyceride catabolic process (GO:0010896) | 4.06860319 |
| 63 | negative regulation of blood coagulation (GO:0030195) | 4.05691179 |
| 64 | negative regulation of hemostasis (GO:1900047) | 4.05691179 |
| 65 | imidazole-containing compound metabolic process (GO:0052803) | 4.05295202 |
| 66 | cellular amino acid catabolic process (GO:0009063) | 4.03457492 |
| 67 | phospholipid efflux (GO:0033700) | 3.94779978 |
| 68 | amine catabolic process (GO:0009310) | 3.91638842 |
| 69 | cellular biogenic amine catabolic process (GO:0042402) | 3.91638842 |
| 70 | amino-acid betaine metabolic process (GO:0006577) | 3.85916279 |
| 71 | regulation of bile acid biosynthetic process (GO:0070857) | 3.78531638 |
| 72 | negative regulation of cholesterol transport (GO:0032375) | 3.78206211 |
| 73 | negative regulation of sterol transport (GO:0032372) | 3.78206211 |
| 74 | arginine metabolic process (GO:0006525) | 3.77841191 |
| 75 | cellular modified amino acid catabolic process (GO:0042219) | 3.77073405 |
| 76 | omega-hydroxylase P450 pathway (GO:0097267) | 3.73128877 |
| 77 | ketone body metabolic process (GO:1902224) | 3.71939902 |
| 78 | cholesterol efflux (GO:0033344) | 3.71453229 |
| 79 | drug catabolic process (GO:0042737) | 3.70661635 |
| 80 | peptidyl-glutamic acid modification (GO:0018200) | 3.68795434 |
| 81 | regulation of humoral immune response (GO:0002920) | 3.66534898 |
| 82 | lipoprotein metabolic process (GO:0042157) | 3.66289922 |
| 83 | negative regulation of coagulation (GO:0050819) | 3.65719488 |
| 84 | indole-containing compound metabolic process (GO:0042430) | 3.62867633 |
| 85 | negative regulation of protein activation cascade (GO:2000258) | 3.62312366 |
| 86 | bile acid and bile salt transport (GO:0015721) | 3.61258134 |
| 87 | cholesterol homeostasis (GO:0042632) | 3.57479481 |
| 88 | negative regulation of wound healing (GO:0061045) | 3.57407982 |
| 89 | cofactor catabolic process (GO:0051187) | 3.55898685 |
| 90 | aldehyde catabolic process (GO:0046185) | 3.54232285 |
| 91 | sterol homeostasis (GO:0055092) | 3.52976569 |
| 92 | benzene-containing compound metabolic process (GO:0042537) | 3.51198771 |
| 93 | plasma lipoprotein particle clearance (GO:0034381) | 3.51182366 |
| 94 | aspartate family amino acid catabolic process (GO:0009068) | 3.50277133 |
| 95 | opsonization (GO:0008228) | 3.50118811 |
| 96 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.48391552 |
| 97 | serine family amino acid metabolic process (GO:0009069) | 3.48106307 |
| 98 | glycine metabolic process (GO:0006544) | 3.46452972 |
| 99 | cholesterol transport (GO:0030301) | 3.46388269 |
| 100 | sterol transport (GO:0015918) | 3.46388269 |
| 101 | NAD biosynthetic process (GO:0009435) | 3.44447688 |
| 102 | organic acid catabolic process (GO:0016054) | 3.43445004 |
| 103 | carboxylic acid catabolic process (GO:0046395) | 3.43445004 |
| 104 | positive regulation of blood coagulation (GO:0030194) | 3.42919276 |
| 105 | positive regulation of hemostasis (GO:1900048) | 3.42919276 |
| 106 | negative regulation of lipase activity (GO:0060192) | 3.41178444 |
| 107 | exogenous drug catabolic process (GO:0042738) | 3.39580609 |
| 108 | cellular glucuronidation (GO:0052695) | 3.38943505 |
| 109 | heme transport (GO:0015886) | 3.35907843 |
| 110 | ethanol metabolic process (GO:0006067) | 3.33520060 |
| 111 | acetyl-CoA metabolic process (GO:0006084) | 3.31493507 |
| 112 | regulation of lipoprotein particle clearance (GO:0010984) | 3.31104148 |
| 113 | fibrinolysis (GO:0042730) | 3.27637875 |
| 114 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.27251298 |
| 115 | complement activation, classical pathway (GO:0006958) | 3.26146025 |
| 116 | dicarboxylic acid catabolic process (GO:0043649) | 3.24875663 |
| 117 | serine family amino acid biosynthetic process (GO:0009070) | 3.23734500 |
| 118 | cytolysis (GO:0019835) | 3.22563295 |
| 119 | plasma lipoprotein particle assembly (GO:0034377) | 3.22090320 |
| 120 | intestinal absorption (GO:0050892) | 3.21973233 |
| 121 | short-chain fatty acid metabolic process (GO:0046459) | 3.20977722 |
| 122 | 2-oxoglutarate metabolic process (GO:0006103) | 3.19947251 |
| 123 | glucuronate metabolic process (GO:0019585) | 3.19853348 |
| 124 | uronic acid metabolic process (GO:0006063) | 3.19853348 |
| 125 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.19045115 |
| 126 | blood coagulation, intrinsic pathway (GO:0007597) | 3.18578038 |
| 127 | low-density lipoprotein particle remodeling (GO:0034374) | 3.16726993 |
| 128 | acute inflammatory response (GO:0002526) | 3.16334968 |
| 129 | ethanol oxidation (GO:0006069) | 3.16158019 |
| 130 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.15895766 |
| 131 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.15895766 |
| 132 | complement activation (GO:0006956) | 3.13811353 |
| 133 | protein activation cascade (GO:0072376) | 3.13397054 |
| 134 | diacylglycerol metabolic process (GO:0046339) | 3.10006431 |
| 135 | positive regulation of coagulation (GO:0050820) | 3.09889651 |
| 136 | NAD metabolic process (GO:0019674) | 3.09846144 |
| 137 | drug metabolic process (GO:0017144) | 3.09786996 |
| 138 | positive regulation of steroid metabolic process (GO:0045940) | 3.09612451 |
| 139 | oxidative demethylation (GO:0070989) | 3.09578283 |
| 140 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.09330501 |
| 141 | L-serine metabolic process (GO:0006563) | 3.08502042 |
| 142 | oxaloacetate metabolic process (GO:0006107) | 3.06737430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.32240467 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.75417450 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.87293323 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.74639985 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.51374793 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.39413392 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.44083612 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.29138746 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.13724951 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.69806028 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.49573073 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.48059478 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.37966271 |
| 14 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.02534423 |
| 15 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.01527597 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.86363681 |
| 17 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.74290903 |
| 18 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.71091063 |
| 19 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.63717208 |
| 20 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.56484825 |
| 21 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.55331732 |
| 22 | P68_20966046_ChIP-Seq_HELA_Human | 1.54677917 |
| 23 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.54333991 |
| 24 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.53541584 |
| 25 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.51767341 |
| 26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.51413446 |
| 27 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.50431202 |
| 28 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.50250907 |
| 29 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.48485766 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.48140070 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.47422899 |
| 32 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.46193507 |
| 33 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.45590165 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.41856373 |
| 35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41550397 |
| 36 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.36548688 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33380110 |
| 38 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.32241840 |
| 39 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.32206421 |
| 40 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.30983264 |
| 41 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.30850437 |
| 42 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.30415827 |
| 43 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.30273145 |
| 44 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.27283072 |
| 45 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.26428083 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25752711 |
| 47 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.25682531 |
| 48 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.25519000 |
| 49 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.24243641 |
| 50 | P300_19829295_ChIP-Seq_ESCs_Human | 1.24012041 |
| 51 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.23825272 |
| 52 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23598071 |
| 53 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.23155053 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21401603 |
| 55 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.20574241 |
| 56 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.20458216 |
| 57 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.20291042 |
| 58 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19550248 |
| 59 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.18226939 |
| 60 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.16125008 |
| 61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15697072 |
| 62 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15231127 |
| 63 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.14385086 |
| 64 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.12897444 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12272888 |
| 66 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12249275 |
| 67 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.11569223 |
| 68 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.11539723 |
| 69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10812428 |
| 70 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.10781358 |
| 71 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.10743627 |
| 72 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.10673598 |
| 73 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.09831467 |
| 74 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09146783 |
| 75 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.08196783 |
| 76 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.08029366 |
| 77 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.08029366 |
| 78 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.05268431 |
| 79 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.04752308 |
| 80 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.04440862 |
| 81 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.03694307 |
| 82 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.02498483 |
| 83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02127534 |
| 84 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02127534 |
| 85 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.99911208 |
| 86 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.99667329 |
| 87 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.99247468 |
| 88 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.99007808 |
| 89 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98473064 |
| 90 | VDR_22108803_ChIP-Seq_LS180_Human | 0.97757805 |
| 91 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.96645687 |
| 92 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96027563 |
| 93 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.95767620 |
| 94 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.95699535 |
| 95 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94811525 |
| 96 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.94764129 |
| 97 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.94300665 |
| 98 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93746048 |
| 99 | SA1_27219007_Chip-Seq_Bcells_Human | 0.93383752 |
| 100 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.92111142 |
| 101 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90197717 |
| 102 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.90121678 |
| 103 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.89937079 |
| 104 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89704779 |
| 105 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.89246135 |
| 106 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.89132567 |
| 107 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.89086350 |
| 108 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.88960098 |
| 109 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.88623150 |
| 110 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88372319 |
| 111 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.87917144 |
| 112 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.87686374 |
| 113 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87372880 |
| 114 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87227858 |
| 115 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87005603 |
| 116 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.86576376 |
| 117 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.85896425 |
| 118 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.84891531 |
| 119 | ERA_21632823_ChIP-Seq_H3396_Human | 0.84745667 |
| 120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.84568504 |
| 121 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84243804 |
| 122 | STAT3_23295773_ChIP-Seq_U87_Human | 0.83897617 |
| 123 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.83623157 |
| 124 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.83605726 |
| 125 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.82832881 |
| 126 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81926755 |
| 127 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.81393572 |
| 128 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81188577 |
| 129 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.81005839 |
| 130 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79339174 |
| 131 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.78155236 |
| 132 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77964876 |
| 133 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77824064 |
| 134 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.77637355 |
| 135 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.77153355 |
| 136 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.77015385 |
| 137 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76284174 |
| 138 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.76162404 |
| 139 | FUS_26573619_Chip-Seq_HEK293_Human | 0.76109163 |
| 140 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75606088 |
| 141 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.75493876 |
| 142 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.75407101 |
| 143 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74849804 |
| 144 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.74727852 |
| 145 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.74535009 |
| 146 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.74228505 |
| 147 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.74176195 |
| 148 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.74025761 |
| 149 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.73962309 |
| 150 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.73560861 |
| 151 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.73203041 |
| 152 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.73088842 |
| 153 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.72713839 |
| 154 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.72580052 |
| 155 | GATA1_22025678_ChIP-Seq_K562_Human | 0.71367054 |
| 156 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.71059661 |
| 157 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.70885311 |
| 158 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.70399992 |
| 159 | TCF4_23295773_ChIP-Seq_U87_Human | 0.70253925 |
| 160 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.70176345 |
| 161 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.69918270 |
| 162 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.68947353 |
| 163 | KDM2B_26808549_Chip-Seq_REH_Human | 0.68727805 |
| 164 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.68486207 |
| 165 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.67574819 |
| 166 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.66169224 |
| 167 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.66130536 |
| 168 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.65454885 |
| 169 | JUN_21703547_ChIP-Seq_K562_Human | 0.65419270 |
| 170 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.64959962 |
| 171 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.64959962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.15151861 |
| 2 | MP0005360_urolithiasis | 6.63567945 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.80625735 |
| 4 | MP0005365_abnormal_bile_salt | 5.48999039 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.69304967 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.84673110 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.42127463 |
| 8 | MP0003252_abnormal_bile_duct | 3.20117170 |
| 9 | MP0003195_calcinosis | 2.79711359 |
| 10 | MP0003122_maternal_imprinting | 2.60439647 |
| 11 | MP0005332_abnormal_amino_acid | 2.59047827 |
| 12 | MP0002822_catalepsy | 2.32294513 |
| 13 | MP0002876_abnormal_thyroid_physiology | 2.30147848 |
| 14 | MP0005083_abnormal_biliary_tract | 2.30145373 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.12141099 |
| 16 | MP0009840_abnormal_foam_cell | 2.09676052 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.08502900 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 1.87189469 |
| 19 | MP0003880_abnormal_central_pattern | 1.86988983 |
| 20 | MP0004859_abnormal_synaptic_plasticity | 1.86272363 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.78037369 |
| 22 | MP0001661_extended_life_span | 1.69412288 |
| 23 | MP0003123_paternal_imprinting | 1.67421211 |
| 24 | MP0000609_abnormal_liver_physiology | 1.60537961 |
| 25 | MP0009697_abnormal_copulation | 1.58620849 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.52768262 |
| 27 | MP0000566_synostosis | 1.50432223 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.48000073 |
| 29 | MP0001986_abnormal_taste_sensitivity | 1.47652900 |
| 30 | MP0009745_abnormal_behavioral_response | 1.45009295 |
| 31 | MP0005408_hypopigmentation | 1.44980713 |
| 32 | MP0003868_abnormal_feces_composition | 1.42743628 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.42075341 |
| 34 | MP0001764_abnormal_homeostasis | 1.40540307 |
| 35 | MP0003635_abnormal_synaptic_transmissio | 1.31484826 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.30543867 |
| 37 | MP0002249_abnormal_larynx_morphology | 1.29562575 |
| 38 | MP0005423_abnormal_somatic_nervous | 1.27106916 |
| 39 | MP0002064_seizures | 1.22618837 |
| 40 | MP0002063_abnormal_learning/memory/cond | 1.21622427 |
| 41 | MP0002089_abnormal_postnatal_growth/wei | 1.20573220 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.19321715 |
| 43 | MP0002736_abnormal_nociception_after | 1.18197978 |
| 44 | MP0005647_abnormal_sex_gland | 1.16297477 |
| 45 | MP0003879_abnormal_hair_cell | 1.13895746 |
| 46 | MP0005646_abnormal_pituitary_gland | 1.11956923 |
| 47 | MP0003329_amyloid_beta_deposits | 1.10408466 |
| 48 | MP0001968_abnormal_touch/_nociception | 1.10355082 |
| 49 | MP0003136_yellow_coat_color | 1.09649428 |
| 50 | MP0004043_abnormal_pH_regulation | 1.09411575 |
| 51 | MP0005451_abnormal_body_composition | 1.09018513 |
| 52 | MP0006292_abnormal_olfactory_placode | 1.08923538 |
| 53 | MP0005636_abnormal_mineral_homeostasis | 1.07678686 |
| 54 | MP0000604_amyloidosis | 1.07087971 |
| 55 | MP0010030_abnormal_orbit_morphology | 1.06193467 |
| 56 | MP0002572_abnormal_emotion/affect_behav | 1.05650577 |
| 57 | MP0001915_intracranial_hemorrhage | 1.03563776 |
| 58 | MP0009046_muscle_twitch | 1.01187170 |
| 59 | MP0003172_abnormal_lysosome_physiology | 0.98892702 |
| 60 | MP0004270_analgesia | 0.98507455 |
| 61 | MP0003567_abnormal_fetal_cardiomyocyte | 0.98106314 |
| 62 | MP0003890_abnormal_embryonic-extraembry | 0.97400228 |
| 63 | MP0002272_abnormal_nervous_system | 0.96151230 |
| 64 | MP0002078_abnormal_glucose_homeostasis | 0.96111121 |
| 65 | MP0002132_abnormal_respiratory_system | 0.95084268 |
| 66 | MP0003011_delayed_dark_adaptation | 0.93159654 |
| 67 | MP0005535_abnormal_body_temperature | 0.92347499 |
| 68 | MP0001501_abnormal_sleep_pattern | 0.90264585 |
| 69 | MP0009643_abnormal_urine_homeostasis | 0.89948993 |
| 70 | MP0003941_abnormal_skin_development | 0.89424402 |
| 71 | MP0002282_abnormal_trachea_morphology | 0.85921057 |
| 72 | MP0002735_abnormal_chemical_nociception | 0.83850167 |
| 73 | MP0006276_abnormal_autonomic_nervous | 0.83546291 |
| 74 | MP0001440_abnormal_grooming_behavior | 0.80393770 |
| 75 | MP0001756_abnormal_urination | 0.79186503 |
| 76 | MP0005084_abnormal_gallbladder_morpholo | 0.77786018 |
| 77 | MP0002254_reproductive_system_inflammat | 0.77649988 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 0.77502246 |
| 79 | MP0003121_genomic_imprinting | 0.77350262 |
| 80 | MP0005377_hearing/vestibular/ear_phenot | 0.76949690 |
| 81 | MP0003878_abnormal_ear_physiology | 0.76949690 |
| 82 | MP0005058_abnormal_lysosome_morphology | 0.76699473 |
| 83 | MP0008874_decreased_physiological_sensi | 0.75822456 |
| 84 | MP0006036_abnormal_mitochondrial_physio | 0.75530892 |
| 85 | MP0005409_darkened_coat_color | 0.75505929 |
| 86 | MP0004133_heterotaxia | 0.75063220 |
| 87 | MP0000003_abnormal_adipose_tissue | 0.74954245 |
| 88 | MP0004130_abnormal_muscle_cell | 0.74767689 |
| 89 | MP0005376_homeostasis/metabolism_phenot | 0.74240420 |
| 90 | MP0009642_abnormal_blood_homeostasis | 0.74202319 |
| 91 | MP0009053_abnormal_anal_canal | 0.74114481 |
| 92 | MP0003186_abnormal_redox_activity | 0.74094338 |
| 93 | MP0010368_abnormal_lymphatic_system | 0.73958135 |
| 94 | MP0000598_abnormal_liver_morphology | 0.73693625 |
| 95 | MP0000751_myopathy | 0.73155272 |
| 96 | MP0005266_abnormal_metabolism | 0.73071637 |
| 97 | MP0005448_abnormal_energy_balance | 0.73066658 |
| 98 | MP0001188_hyperpigmentation | 0.71899266 |
| 99 | MP0002067_abnormal_sensory_capabilities | 0.71521727 |
| 100 | MP0004142_abnormal_muscle_tone | 0.71504211 |
| 101 | MP0008872_abnormal_physiological_respon | 0.69367179 |
| 102 | MP0005551_abnormal_eye_electrophysiolog | 0.68444572 |
| 103 | MP0000013_abnormal_adipose_tissue | 0.68317186 |
| 104 | MP0001293_anophthalmia | 0.67975313 |
| 105 | MP0001486_abnormal_startle_reflex | 0.67351574 |
| 106 | MP0001984_abnormal_olfaction | 0.67196238 |
| 107 | MP0005257_abnormal_intraocular_pressure | 0.67182075 |
| 108 | MP0003638_abnormal_response/metabolism_ | 0.67122822 |
| 109 | MP0001765_abnormal_ion_homeostasis | 0.66959724 |
| 110 | MP0003633_abnormal_nervous_system | 0.66482352 |
| 111 | MP0005670_abnormal_white_adipose | 0.66263727 |
| 112 | MP0002069_abnormal_eating/drinking_beha | 0.65917827 |
| 113 | MP0006035_abnormal_mitochondrial_morpho | 0.65841104 |
| 114 | MP0009384_cardiac_valve_regurgitation | 0.65336772 |
| 115 | MP0005330_cardiomyopathy | 0.65164160 |
| 116 | MP0009672_abnormal_birth_weight | 0.64236809 |
| 117 | MP0001324_abnormal_eye_pigmentation | 0.63536678 |
| 118 | MP0003718_maternal_effect | 0.63312990 |
| 119 | MP0003953_abnormal_hormone_level | 0.63169051 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.61866173 |
| 121 | MP0002971_abnormal_brown_adipose | 0.60856286 |
| 122 | MP0002909_abnormal_adrenal_gland | 0.59915221 |
| 123 | MP0003690_abnormal_glial_cell | 0.59826034 |
| 124 | MP0002734_abnormal_mechanical_nocicepti | 0.59435607 |
| 125 | MP0009764_decreased_sensitivity_to | 0.59277548 |
| 126 | MP0005595_abnormal_vascular_smooth | 0.56706138 |
| 127 | MP0000639_abnormal_adrenal_gland | 0.55972556 |
| 128 | MP0002697_abnormal_eye_size | 0.55471901 |
| 129 | MP0003119_abnormal_digestive_system | 0.55363984 |
| 130 | MP0003787_abnormal_imprinting | 0.55026184 |
| 131 | MP0003631_nervous_system_phenotype | 0.54916796 |
| 132 | MP0005334_abnormal_fat_pad | 0.54407001 |
| 133 | MP0002160_abnormal_reproductive_system | 0.54159032 |
| 134 | MP0005410_abnormal_fertilization | 0.53346468 |
| 135 | MP0002733_abnormal_thermal_nociception | 0.52475983 |
| 136 | MP0004272_abnormal_basement_membrane | 0.51210166 |
| 137 | MP0005076_abnormal_cell_differentiation | 0.49784182 |
| 138 | MP0009763_increased_sensitivity_to | 0.48636762 |
| 139 | MP0002092_abnormal_eye_morphology | 0.48570239 |
| 140 | MP0002938_white_spotting | 0.48072051 |
| 141 | MP0003115_abnormal_respiratory_system | 0.47788253 |
| 142 | MP0005395_other_phenotype | 0.47142743 |
| 143 | MP0003183_abnormal_peptide_metabolism | 0.47019836 |
| 144 | MP0002557_abnormal_social/conspecific_i | 0.44920240 |
| 145 | MP0009765_abnormal_xenobiotic_induced | 0.44537334 |
| 146 | MP0005220_abnormal_exocrine_pancreas | 0.44452476 |
| 147 | MP0005394_taste/olfaction_phenotype | 0.44222619 |
| 148 | MP0005499_abnormal_olfactory_system | 0.44222619 |
| 149 | MP0003075_altered_response_to | 0.44114947 |
| 150 | MP0003315_abnormal_perineum_morphology | 0.43916091 |
| 151 | MP0003942_abnormal_urinary_system | 0.43790394 |
| 152 | MP0002928_abnormal_bile_duct | 0.43374539 |
| 153 | MP0004858_abnormal_nervous_system | 0.42422614 |
| 154 | MP0003632_abnormal_nervous_system | 0.41536736 |
| 155 | MP0001730_embryonic_growth_arrest | 0.39044873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.41942958 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.12712031 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.00790725 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 5.76232729 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.56312246 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.49408091 |
| 7 | Xanthomatosis (HP:0000991) | 4.99697166 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.69727680 |
| 9 | Complement deficiency (HP:0004431) | 4.44390086 |
| 10 | Hemorrhage of the eye (HP:0011885) | 4.15030317 |
| 11 | Joint hemorrhage (HP:0005261) | 3.97973478 |
| 12 | Hypolipoproteinemia (HP:0010981) | 3.97809392 |
| 13 | Hyperglycinemia (HP:0002154) | 3.97312973 |
| 14 | Hyperammonemia (HP:0001987) | 3.92713570 |
| 15 | Conjugated hyperbilirubinemia (HP:0002908) | 3.91658120 |
| 16 | Ketosis (HP:0001946) | 3.87618173 |
| 17 | Glomerulonephritis (HP:0000099) | 3.87568007 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.87450923 |
| 19 | Hyperglycinuria (HP:0003108) | 3.75702689 |
| 20 | Hyperventilation (HP:0002883) | 3.75332350 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 3.74849859 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.72861128 |
| 23 | Focal motor seizures (HP:0011153) | 3.71680765 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.63523482 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.62063883 |
| 26 | Epidermoid cyst (HP:0200040) | 3.58848993 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.54285752 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.54285752 |
| 29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.50847850 |
| 30 | Fat malabsorption (HP:0002630) | 3.42822903 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 3.42323054 |
| 32 | Vaginal fistula (HP:0004320) | 3.37499028 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.36111479 |
| 34 | Gout (HP:0001997) | 3.07116574 |
| 35 | Abnormality of complement system (HP:0005339) | 3.06090590 |
| 36 | * Spontaneous abortion (HP:0005268) | 3.03957836 |
| 37 | Hypoglycemic coma (HP:0001325) | 3.03919208 |
| 38 | Ketoacidosis (HP:0001993) | 3.00267208 |
| 39 | Abnormal gallbladder physiology (HP:0012438) | 2.95133987 |
| 40 | Cholecystitis (HP:0001082) | 2.95133987 |
| 41 | Hyperbilirubinemia (HP:0002904) | 2.94127451 |
| 42 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.93369921 |
| 43 | Metabolic acidosis (HP:0001942) | 2.90128685 |
| 44 | Acanthocytosis (HP:0001927) | 2.84925285 |
| 45 | Cerebral edema (HP:0002181) | 2.84843674 |
| 46 | Abnormality of serum amino acid levels (HP:0003112) | 2.80711679 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 2.76036599 |
| 48 | Status epilepticus (HP:0002133) | 2.75489585 |
| 49 | Abnormal gallbladder morphology (HP:0012437) | 2.70626560 |
| 50 | Mitral stenosis (HP:0001718) | 2.70063723 |
| 51 | Lethargy (HP:0001254) | 2.70001693 |
| 52 | Abnormality of nucleobase metabolism (HP:0010932) | 2.69104580 |
| 53 | Hypercholesterolemia (HP:0003124) | 2.68023493 |
| 54 | Menorrhagia (HP:0000132) | 2.67848014 |
| 55 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.67057373 |
| 56 | Skin nodule (HP:0200036) | 2.60898980 |
| 57 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.59348215 |
| 58 | Delayed CNS myelination (HP:0002188) | 2.57015117 |
| 59 | Abnormality of purine metabolism (HP:0004352) | 2.56971909 |
| 60 | Steatorrhea (HP:0002570) | 2.51577610 |
| 61 | Gingival bleeding (HP:0000225) | 2.46930844 |
| 62 | Cholelithiasis (HP:0001081) | 2.45961870 |
| 63 | Epileptic encephalopathy (HP:0200134) | 2.45625179 |
| 64 | Neonatal onset (HP:0003623) | 2.43879847 |
| 65 | Rectovaginal fistula (HP:0000143) | 2.43219112 |
| 66 | Rectal fistula (HP:0100590) | 2.43219112 |
| 67 | Spastic diplegia (HP:0001264) | 2.42026055 |
| 68 | Abnormality of the lower motor neuron (HP:0002366) | 2.41383670 |
| 69 | Hypoglycemic seizures (HP:0002173) | 2.40961617 |
| 70 | Opisthotonus (HP:0002179) | 2.40587629 |
| 71 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.40128844 |
| 72 | Dicarboxylic aciduria (HP:0003215) | 2.39703761 |
| 73 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.39703761 |
| 74 | Generalized aminoaciduria (HP:0002909) | 2.39388989 |
| 75 | Nephritis (HP:0000123) | 2.37916908 |
| 76 | Increased serum pyruvate (HP:0003542) | 2.37278387 |
| 77 | Brushfield spots (HP:0001088) | 2.35000475 |
| 78 | Sensorimotor neuropathy (HP:0007141) | 2.34687896 |
| 79 | Rickets (HP:0002748) | 2.32998839 |
| 80 | Enlarged kidneys (HP:0000105) | 2.32937030 |
| 81 | Focal seizures (HP:0007359) | 2.32507628 |
| 82 | Abnormal biliary tract physiology (HP:0012439) | 2.22196689 |
| 83 | Bile duct proliferation (HP:0001408) | 2.22196689 |
| 84 | Vomiting (HP:0002013) | 2.21559546 |
| 85 | Abnormality of glycolysis (HP:0004366) | 2.21347228 |
| 86 | Osteomalacia (HP:0002749) | 2.20763665 |
| 87 | Atonic seizures (HP:0010819) | 2.20626214 |
| 88 | Reduced antithrombin III activity (HP:0001976) | 2.19933191 |
| 89 | Hyperphosphaturia (HP:0003109) | 2.18300749 |
| 90 | Intestinal fistula (HP:0100819) | 2.17309784 |
| 91 | Abnormality of the gallbladder (HP:0005264) | 2.16908156 |
| 92 | Vascular calcification (HP:0004934) | 2.16808387 |
| 93 | Abnormal tarsal ossification (HP:0008369) | 2.13686506 |
| 94 | Choanal stenosis (HP:0000452) | 2.11846589 |
| 95 | Testicular atrophy (HP:0000029) | 2.11752658 |
| 96 | Arthropathy (HP:0003040) | 2.11436629 |
| 97 | Irritability (HP:0000737) | 2.10692840 |
| 98 | Abnormal urine phosphate concentration (HP:0012599) | 2.10608929 |
| 99 | Hepatocellular carcinoma (HP:0001402) | 2.10217592 |
| 100 | Malnutrition (HP:0004395) | 2.09824982 |
| 101 | Abnormality of carpal bone ossification (HP:0006257) | 2.08800901 |
| 102 | Purpura (HP:0000979) | 2.06619168 |
| 103 | Widely patent fontanelles and sutures (HP:0004492) | 2.05987772 |
| 104 | Systemic lupus erythematosus (HP:0002725) | 2.05442828 |
| 105 | Fair hair (HP:0002286) | 2.03941548 |
| 106 | Dialeptic seizures (HP:0011146) | 2.01969859 |
| 107 | Acute hepatic failure (HP:0006554) | 1.98585118 |
| 108 | Acute encephalopathy (HP:0006846) | 1.98187012 |
| 109 | Febrile seizures (HP:0002373) | 1.97561140 |
| 110 | Cardiovascular calcification (HP:0011915) | 1.97166577 |
| 111 | Mesangial abnormality (HP:0001966) | 1.97140274 |
| 112 | Generalized tonic-clonic seizures (HP:0002069) | 1.96594433 |
| 113 | Myocardial infarction (HP:0001658) | 1.96000738 |
| 114 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.95013910 |
| 115 | Amyloidosis (HP:0011034) | 1.92118295 |
| 116 | Absence seizures (HP:0002121) | 1.91482936 |
| 117 | Rib fusion (HP:0000902) | 1.90479335 |
| 118 | Alkalosis (HP:0001948) | 1.89204995 |
| 119 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.88155130 |
| 120 | Lower limb hyperreflexia (HP:0002395) | 1.87973834 |
| 121 | Glycosuria (HP:0003076) | 1.86921898 |
| 122 | Abnormality of urine glucose concentration (HP:0011016) | 1.86921898 |
| 123 | Confusion (HP:0001289) | 1.86842996 |
| 124 | Hyperuricemia (HP:0002149) | 1.86046886 |
| 125 | Increased purine levels (HP:0004368) | 1.86046886 |
| 126 | Abnormality of the lumbar spine (HP:0100712) | 1.85152443 |
| 127 | * Thrombophlebitis (HP:0004418) | 1.84979170 |
| 128 | Chronic hepatic failure (HP:0100626) | 1.84606651 |
| 129 | Epileptiform EEG discharges (HP:0011182) | 1.83020774 |
| 130 | Abnormality of the Achilles tendon (HP:0005109) | 1.82558181 |
| 131 | Atrioventricular block (HP:0001678) | 1.79779039 |
| 132 | Ulnar bowing (HP:0003031) | 1.79429768 |
| 133 | Poor suck (HP:0002033) | 1.78988022 |
| 134 | Epiphyseal stippling (HP:0010655) | 1.78389075 |
| 135 | Facial shape deformation (HP:0011334) | 1.78298745 |
| 136 | Potter facies (HP:0002009) | 1.78298745 |
| 137 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.78162925 |
| 138 | Oligomenorrhea (HP:0000876) | 1.78117784 |
| 139 | Poikilocytosis (HP:0004447) | 1.77612438 |
| 140 | Small epiphyses (HP:0010585) | 1.75249816 |
| 141 | Hypophosphatemic rickets (HP:0004912) | 1.74920682 |
| 142 | Popliteal pterygium (HP:0009756) | 1.70170449 |
| 143 | Broad alveolar ridges (HP:0000187) | 1.66052139 |
| 144 | Hepatoblastoma (HP:0002884) | 1.64904150 |
| 145 | Abnormality of the vitreous humor (HP:0004327) | 1.64324573 |
| 146 | Facial hemangioma (HP:0000329) | 1.63699748 |
| 147 | * Abnormal delivery (HP:0001787) | 1.61809905 |
| 148 | Absent epiphyses (HP:0010577) | 1.53680891 |
| 149 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.53680891 |
| 150 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.52247739 |
| 151 | Abnormality of alanine metabolism (HP:0010916) | 1.52247739 |
| 152 | Hyperalaninemia (HP:0003348) | 1.52247739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 4.54298013 |
| 2 | CASK | 4.48070121 |
| 3 | BCKDK | 3.90554708 |
| 4 | EPHA4 | 3.78061003 |
| 5 | NTRK3 | 3.48405387 |
| 6 | AKT3 | 3.45320434 |
| 7 | DAPK2 | 3.29221767 |
| 8 | BMPR2 | 3.04330591 |
| 9 | ICK | 2.95452293 |
| 10 | MAP2K4 | 2.78901485 |
| 11 | MAP3K4 | 2.32577511 |
| 12 | DAPK1 | 2.30648362 |
| 13 | FGFR3 | 2.27408669 |
| 14 | SIK1 | 2.25328206 |
| 15 | MAP2K7 | 2.18004295 |
| 16 | STK16 | 2.08701192 |
| 17 | ERBB3 | 2.05398304 |
| 18 | PRPF4B | 2.03448208 |
| 19 | ERBB4 | 1.95376751 |
| 20 | ERN1 | 1.91806719 |
| 21 | PKN2 | 1.90678530 |
| 22 | INSRR | 1.87965793 |
| 23 | MAP3K12 | 1.83219602 |
| 24 | SIK3 | 1.82612388 |
| 25 | NME1 | 1.75020459 |
| 26 | BMPR1B | 1.74431556 |
| 27 | FGFR4 | 1.73417229 |
| 28 | ACVR1B | 1.71667141 |
| 29 | RIPK1 | 1.68549234 |
| 30 | TRIB3 | 1.63778326 |
| 31 | PRKCG | 1.59139224 |
| 32 | TYRO3 | 1.58089086 |
| 33 | WNK1 | 1.58046396 |
| 34 | MUSK | 1.56065608 |
| 35 | CAMK1D | 1.53464228 |
| 36 | SGK2 | 1.49967434 |
| 37 | DYRK1B | 1.46924489 |
| 38 | CDK12 | 1.42456094 |
| 39 | PLK2 | 1.36048768 |
| 40 | FRK | 1.35353911 |
| 41 | LATS2 | 1.35218921 |
| 42 | CDK19 | 1.35192613 |
| 43 | PTK2B | 1.29612927 |
| 44 | NEK2 | 1.20757272 |
| 45 | PDGFRA | 1.19725870 |
| 46 | PINK1 | 1.19257715 |
| 47 | OXSR1 | 1.18926474 |
| 48 | SGK3 | 1.17989752 |
| 49 | TSSK6 | 1.17158972 |
| 50 | SGK494 | 1.16658040 |
| 51 | SGK223 | 1.16658040 |
| 52 | CAMK2B | 1.12426007 |
| 53 | SMG1 | 1.11498126 |
| 54 | STK39 | 1.09392841 |
| 55 | CAMK2G | 1.09024621 |
| 56 | CSNK1E | 1.08650780 |
| 57 | FGFR2 | 1.07544140 |
| 58 | MAPK7 | 1.03878214 |
| 59 | PBK | 1.01791536 |
| 60 | PDK3 | 1.01680732 |
| 61 | PDK4 | 1.01680732 |
| 62 | CAMK2A | 1.00756314 |
| 63 | MAPK11 | 0.97173265 |
| 64 | STK38L | 0.96442558 |
| 65 | CDK7 | 0.95405776 |
| 66 | GRK6 | 0.94864068 |
| 67 | ERBB2 | 0.94369739 |
| 68 | PIK3CA | 0.93673193 |
| 69 | CAMK1G | 0.86211710 |
| 70 | MINK1 | 0.84832728 |
| 71 | PTK2 | 0.83530034 |
| 72 | MAP3K7 | 0.82706739 |
| 73 | BRAF | 0.82306711 |
| 74 | PLK4 | 0.81341149 |
| 75 | CSNK1D | 0.80149530 |
| 76 | BMX | 0.79835231 |
| 77 | NTRK2 | 0.79041086 |
| 78 | ADRBK2 | 0.76747936 |
| 79 | SIK2 | 0.76389410 |
| 80 | CDC7 | 0.74172276 |
| 81 | MST1R | 0.74169943 |
| 82 | TNIK | 0.73059183 |
| 83 | GRK5 | 0.72255663 |
| 84 | CCNB1 | 0.71716096 |
| 85 | MAPK15 | 0.71263368 |
| 86 | MAP3K10 | 0.68604235 |
| 87 | EIF2AK1 | 0.68383937 |
| 88 | PRKCZ | 0.67431848 |
| 89 | BUB1 | 0.65682696 |
| 90 | BRSK1 | 0.65444475 |
| 91 | LATS1 | 0.65211429 |
| 92 | PRKCE | 0.63861728 |
| 93 | CAMK4 | 0.63545516 |
| 94 | CSNK2A2 | 0.62463369 |
| 95 | CDK15 | 0.62359557 |
| 96 | EEF2K | 0.62176668 |
| 97 | DYRK2 | 0.62100574 |
| 98 | MAPK12 | 0.61858537 |
| 99 | OBSCN | 0.60266273 |
| 100 | CDK4 | 0.59525106 |
| 101 | PLK1 | 0.59189073 |
| 102 | TTK | 0.58076199 |
| 103 | CDK11A | 0.57774350 |
| 104 | MTOR | 0.57654849 |
| 105 | DAPK3 | 0.57640225 |
| 106 | NEK9 | 0.57087638 |
| 107 | CSNK2A1 | 0.56666424 |
| 108 | TAOK3 | 0.56209860 |
| 109 | AKT2 | 0.54759562 |
| 110 | PTK6 | 0.54335045 |
| 111 | CDK18 | 0.54319452 |
| 112 | FER | 0.54079518 |
| 113 | PDK2 | 0.52371705 |
| 114 | MYLK | 0.52140378 |
| 115 | RET | 0.51809951 |
| 116 | GRK1 | 0.50563888 |
| 117 | PRKACG | 0.50130291 |
| 118 | PDK1 | 0.49919344 |
| 119 | SRPK1 | 0.49547113 |
| 120 | CDK1 | 0.49348276 |
| 121 | MAP3K6 | 0.48892863 |
| 122 | SGK1 | 0.48680256 |
| 123 | CAMK2D | 0.47936198 |
| 124 | MAP3K13 | 0.47912825 |
| 125 | CDC42BPA | 0.47609013 |
| 126 | PIK3CG | 0.47541311 |
| 127 | RPS6KB1 | 0.47539490 |
| 128 | CDK8 | 0.47289235 |
| 129 | CDK5 | 0.47121691 |
| 130 | IRAK2 | 0.46836769 |
| 131 | PRKAA2 | 0.46662684 |
| 132 | ABL2 | 0.46651603 |
| 133 | MAPK13 | 0.44916135 |
| 134 | NTRK1 | 0.44430030 |
| 135 | MKNK2 | 0.43892754 |
| 136 | CDK2 | 0.43099839 |
| 137 | ADRBK1 | 0.42742455 |
| 138 | PRKCA | 0.42681622 |
| 139 | DDR2 | 0.42398031 |
| 140 | PRKACA | 0.41198563 |
| 141 | FGFR1 | 0.40718346 |
| 142 | ATR | 0.40429141 |
| 143 | JAK2 | 0.40346801 |
| 144 | RIPK4 | 0.39273180 |
| 145 | ARAF | 0.39100617 |
| 146 | PHKG1 | 0.38747491 |
| 147 | PHKG2 | 0.38747491 |
| 148 | STK38 | 0.37404492 |
| 149 | MATK | 0.37201278 |
| 150 | CDK3 | 0.36096010 |
| 151 | KSR1 | 0.35210904 |
| 152 | MAPK8 | 0.35118610 |
| 153 | GSK3B | 0.33910410 |
| 154 | PRKCB | 0.33787046 |
| 155 | WNK3 | 0.33614309 |
| 156 | PRKAA1 | 0.33414173 |
| 157 | CAMKK1 | 0.33155467 |
| 158 | MARK2 | 0.32930376 |
| 159 | PRKDC | 0.32588340 |
| 160 | RPS6KA3 | 0.32460082 |
| 161 | PRKCH | 0.30191634 |
| 162 | PRKG1 | 0.29439570 |
| 163 | MAPK4 | 0.27848298 |
| 164 | PDPK1 | 0.26751380 |
| 165 | MAP2K6 | 0.26146542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.30181094 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.80748225 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.06454557 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.77033250 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.76886833 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.73749504 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63536053 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.48437032 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.41431918 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.33264787 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.26477185 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.25005624 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.14499293 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.04063348 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.02936704 |
| 16 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.89230967 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.82260031 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.82215125 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.78536607 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.78493253 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.76053737 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.71974959 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.71597825 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.69980877 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.65785203 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.62304593 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.62202802 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.61569764 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.58836770 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58814800 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47368665 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.44978809 |
| 33 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.43880706 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.42518154 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.41420484 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35193285 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.33728482 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28676193 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.26898783 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.26812154 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22912687 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.21590712 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.20627976 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.19964126 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18554040 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12389566 |
| 47 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.12175454 |
| 48 | Other glycan degradation_Homo sapiens_hsa00511 | 1.11335992 |
| 49 | Nicotine addiction_Homo sapiens_hsa05033 | 1.05086494 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.01362752 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.99860270 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.99724974 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.92987182 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90173478 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90121508 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88307445 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84624394 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81849187 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.81681047 |
| 60 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.80365112 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80042030 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79057393 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78789520 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.74620765 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63447623 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.62787237 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60290664 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57165928 |
| 69 | GABAergic synapse_Homo sapiens_hsa04727 | 0.56806903 |
| 70 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54809496 |
| 71 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54051357 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.50187180 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49568155 |
| 74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49366038 |
| 75 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.49266128 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48199243 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42620470 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39870466 |
| 79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.39635661 |
| 80 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.37228267 |
| 81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.37009232 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36902178 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35853526 |
| 84 | Circadian entrainment_Homo sapiens_hsa04713 | 0.34854570 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.33862238 |
| 86 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.33141607 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32268884 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31583319 |
| 89 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.31503424 |
| 90 | Taste transduction_Homo sapiens_hsa04742 | 0.31225179 |
| 91 | Morphine addiction_Homo sapiens_hsa05032 | 0.30200812 |
| 92 | Olfactory transduction_Homo sapiens_hsa04740 | 0.29741949 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29521119 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.24631173 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.24592855 |
| 96 | Insulin secretion_Homo sapiens_hsa04911 | 0.23896186 |
| 97 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.23703499 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23583635 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.22617978 |
| 100 | Proteasome_Homo sapiens_hsa03050 | 0.22033399 |
| 101 | Long-term potentiation_Homo sapiens_hsa04720 | 0.21533479 |
| 102 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.17710176 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.16302959 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.15341228 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.13027434 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.11441381 |
| 107 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.10235540 |
| 108 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09830892 |
| 109 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.09793706 |
| 110 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.08650454 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.08514176 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | 0.05647815 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.03124223 |
| 114 | Salivary secretion_Homo sapiens_hsa04970 | 0.03114490 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01487332 |
| 116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0539545 |
| 117 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.0522004 |
| 118 | Non-homologous end-joining_Homo sapiens_hsa03450 | -0.0444429 |
| 119 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0261447 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0156415 |
| 121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0102866 |
| 122 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0038512 |
| 123 | Pertussis_Homo sapiens_hsa05133 | -0.0009090 |

